A Case of Malaria

John Lenard originates from Alabama district of the United States of America-a district which is popularly renowned for the presence of Plasmodium-infected mosquitos. Therefore, the likelihood of his sickness is malaria based on his reporting of his feelings which are more consistent with the disease symptoms.

John was initially diagnosed with the disease in the summer of October 2017 and was successfully treated through administration of antimicrobials used to treat the last stage of malaria. Over this time, significant cases of the similar disease were reported across the district hospitals and thus the disease largely affiliated to the winter climate which supported the bleeding of the parasite. It is until then that the case has recurred to John.

Objective

On conducting the physical examination, it was found that Lenard had symptoms ranging from abdominal pain, high fever, nausea, headache, muscle pain, vomiting, profuse sweating, as well as moderate shaking chills. Moreover, it was discovered that the symptoms had persistently lasted for a week which led the patient to seek medical attention. As such, the patient was diagnosed with stage four of the malaria parasite.

Malaria rapid diagnostic tests were carried out to enable detection of malaria antigens in human blood; this was through microscopy.

Assessment

As a result of our examination, Lenard is suffering from malaria due to the malaria antigen present in his blood. The malaria antigen present in his blood is Plasmodium falciparum (p.f) which is the most deadly parasite responsible for multiple infections and malaria-related deaths. Fatigue, joint pain, dizziness, aching muscles, abdominal pain, enlarged spleen, sore back, fever, sore back, vomiting, headache and neurological symptoms are most common with patients suffering this antigen infection. It is worth treating the disease in time due to its severity as compared to the other three types of malaria.

Plan

Diagnostic plan

The patient should seek the diagnosis of the same problem after one month of treatment to assess the progress of treatment or in other words the extent to which the parasite has been depleted.

Treatment plan

Treatment of Plasmodium falciparum (P.f) takes three days with either of the following ACTs prescription: artemether+lumefantrime or artsunate+amodiaquine.

Patient education

Lenard should be briefed on the importance of sleeping under a well-treated mosquito net as well as maintaining a surrounding free from mosquito bleeding.

Planned-follow up

John should be attached to a social worker who will ensure that the patient adheres to the conditions of clean environment that do not support mosquito bleeding. The patient will maintain regular visits to the medical center in the next two weeks for his health review (Epstein et al, 2017).

Medical examination done by: Dennis Carson

Position: Medical Doctor

Signature: D.C

References

Epstein, J. E., Paolino, K. M., Richie, T. L., Sedegah, M., Singer, A., Ruben, A. J., ... & Li, T. (2017). Protection against Plasmodium falciparum malaria by PfSPZ Vaccine. JCI insight, 2(1).